| First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients (NCT04858269) | Wake Forest University Health Sciences | 2021-05-27 |
| Swallowing Function in Patients With Head and Neck Cancers (NCT05833841) | Banaras Hindu University | 2021-05-01 |
| Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer (NCT04566367) | Georg Dultz | 2020-09-22 |
| DRIHNC - Dehydration Reduction in Head & Neck Cancer (NCT03799380) | Case Comprehensive Cancer Center | 2019-11-05 |
| Carotid PET/MRI With DOTATATE in Patients Post Head and Neck Radiation Therapy (NCT04040166) | University Health Network, Toronto | 2019-08-22 |
| Investigation of Two Swallowing Therapy Models During Radiation Therapy for Head and Neck Cancer (NCT03832686) | Stanford University | 2019-04-22 |
| Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients. (NCT03747562) | University Hospital, Ghent | 2019-03-01 |
| Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy (NCT03712397) | National Health Research Institutes, Taiwan | 2018-12-24 |
| Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC (NCT03572829) | Chinese Academy of Medical Sciences | 2018-03-01 |
| Newer Therapeutic Targets in Head and Neck Cancers (NCT05382585) | Banaras Hindu University | 2017-04-01 |
| Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors (NCT03065062) | Dana-Farber Cancer Institute | 2017-02-28 |
| Real-World Evidence and Treatment Patterns: Head and Neck Cancer (NCT03157674) | Bristol-Myers Squibb | 2016-11-24 |
| Calcium Electroporation for Head and Neck Cancer (NCT03051269) | Rigshospitalet, Denmark | 2016-05-01 |
| A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT02521870) | Dynavax Technologies Corporation | 2015-09-01 |
| PCA062 in pCAD-positive Tumors. (NCT02375958) | Novartis Pharmaceuticals | 2015-04-15 |
| Brief Intraoperative Electrical Stimulation for Prevention of Shoulder Dysfunction After Oncologic Neck Dissection (NCT02268344) | University of Alberta | 2014-10-06 |
| Electrochemotherapy on Head and Neck Cancer (NCT02549742) | Rigshospitalet, Denmark | 2014-02-01 |
| Intensive Nutritional Counseling in Head-neck Cancer Patients Undergoing Radiotherapy (NCT02055833) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2013-09-01 |
| Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors (NCT01951664) | Vanderbilt-Ingram Cancer Center | 2013-08-01 |
| Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer (NCT02075385) | Barretos Cancer Hospital | 2012-07-01 |
| Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma (NCT01268579) | Memorial Sloan Kettering Cancer Center | 2010-12-28 |
| RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer (NCT00935961) | Memorial Sloan Kettering Cancer Center | 2009-07-01 |
| Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT00736619) | Memorial Sloan Kettering Cancer Center | 2008-08-01 |
| Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma (NCT00198328) | Inovio Pharmaceuticals | 2004-11-01 |